Skip to main content
. 2022 Jun 23;82(16):2928–2939. doi: 10.1158/0008-5472.CAN-21-3106

Table 3.

Lung and ovary positivity by IVIS shown as a table from Fig. 3E.

Experimental group Lung positive by IVIS Ovary positive by IVIS
Vehicle 5/8 6/8
Fulvestrant 6/8 0/8
Neratinib 5/8 5/8
Neratinib + fulvestrant 7/7 2/7
Poziotinib 0/3 0/3
Poziotinib + fulvestrant 0/7 0/7